Dr. Robert Huizinga reports

KANE BIOTECH RECEIVES HEALTH CANADA APPROVAL FOR REVYVE ANTIMICROBIAL WOUND GEL SPRAY

Health Canada has approved Kane Biotech Inc.'s revyve anti-microbial wound gel spray for use in Canada.

revyve anti-microbial wound gel spray has been previously cleared under the Food and Drug Administration 510(k) process. This Health Canada approval represents another regulatory milestone for Kane and the company's commitment to advancing wound care innovation in Canada. The revyve anti-microbial wound gel spray is designed to support clinicians in managing complex wounds by helping to reduce microbial burden and promote a healthier wound environment.

Health Canada approval provides clinicians and patients in Canada with access to a new wound care option for managing burns, large surface area wounds and ulcers. The spray is part of Kane Biotech's revyve wound care portfolio, which has been evaluated in multiple clinical settings in the United States.

Dr. Robert B. Huizinga, interim chief executive officer of Kane Biotech, commented: "Health Canada's approval of the revyve anti-microbial wound gel spray is another step forward in our mission to improve outcomes for patients with chronic and hard-to-heal wounds. This approval validates the strength of our clinical data and provides Canadian health care providers with a new tool to address the burden of wound infections."

The company will work closely with health care partners and distributors to ensure appropriate access and education around the use of revyve anti-microbial wound gel spray. Kane Biotech continues to advance its wound care portfolio, including the recent FDA submission of revyve anti-microbial wound and skin cleanser as the company's third product in its revyve product line.

About Kane Biotech Inc.

Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds, which results in serious clinical outcomes and significant cost. revyve addresses both biofilms and wound bacteria. revyve anti-microbial wound gel and revyve anti-microbial wound gel spray are U.S. FDA 510(k) cleared. revyve anti-microbial wound gel is Health Canada approved.

We seek Safe Harbor.